Taken together, our work has uncovered a previously unrecognized regulation of Hippo pathway via MEKK2 and MEKK3 and provides new insights into molecular mechanisms for the interplay between Hippo-YAP and NF-κB signaling and the pathogenesis of CCM disease. Here, MAP3K3 is linked to cerebral cavernous malformation.